MBX Biosciences, Inc. Common Stock (MBX)
Oxford Ledge is still expanding full research coverage of MBX. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Clinical-stage biopharmaceutical company developing precision peptide therapies for endocrine and metabolic disorders with multiple candidates in clinical trials.
SEC filings
- 8-K Departure/election of directors or officers 2026-07-13
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-06-12
- 8-K Departure/election of directors or officers; Shareholder vote results 2026-06-05
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-05-11
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-05-07
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for MBX. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open MBX in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.